206 related articles for article (PubMed ID: 15637639)
21. Clozapine pre-treatment has a protracted hypolocomotor effect on the induction and expression of amphetamine sensitization.
Herrera AS; Casanova JP; Gatica RI; Escobar F; Fuentealba JA
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():1-6. PubMed ID: 23954739
[TBL] [Abstract][Full Text] [Related]
22. Expression of amphetamine-induced behavioral sensitization after short- and long-term withdrawal periods: participation of mu- and delta-opioid receptors.
Magendzo K; Bustos G
Neuropsychopharmacology; 2003 Mar; 28(3):468-77. PubMed ID: 12629526
[TBL] [Abstract][Full Text] [Related]
23. Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion.
Norman C; Beckett SR; Spicer CH; Ashton D; Langlois X; Bennett GW
J Psychopharmacol; 2008 May; 22(3):300-7. PubMed ID: 18208905
[TBL] [Abstract][Full Text] [Related]
24. The laterodorsal tegmentum contributes to behavioral sensitization to amphetamine.
Nelson CL; Wetter JB; Milovanovic M; Wolf ME
Neuroscience; 2007 Apr; 146(1):41-9. PubMed ID: 17321058
[TBL] [Abstract][Full Text] [Related]
25. Effects of the selective neurotensin antagonist SR 142948A on 3,4-methylenedioxymethamphetamine-induced behaviours in mice.
Marie-Claire C; Palminteri S; Romualdi P; Noble F
Neuropharmacology; 2008 Jun; 54(7):1107-11. PubMed ID: 18410947
[TBL] [Abstract][Full Text] [Related]
26. Blockade of beta-adrenergic receptors prevents amphetamine-induced behavioural sensitization in rats: a putative role of the bed nucleus of the stria terminalis.
Colussi-Mas J; Panayi F; Scarna H; Renaud B; Bérod A; Lambás-Señas L
Int J Neuropsychopharmacol; 2005 Dec; 8(4):569-81. PubMed ID: 15836801
[TBL] [Abstract][Full Text] [Related]
27. Long-term behavioral and neuronal cross-sensitization to amphetamine induced by repeated brief social defeat stress: Fos in the ventral tegmental area and amygdala.
Nikulina EM; Covington HE; Ganschow L; Hammer RP; Miczek KA
Neuroscience; 2004; 123(4):857-65. PubMed ID: 14751279
[TBL] [Abstract][Full Text] [Related]
28. Netrin-1 receptor in the ventral tegmental area is required for sensitization to amphetamine.
Yetnikoff L; Eng C; Benning S; Flores C
Eur J Neurosci; 2010 Apr; 31(7):1292-302. PubMed ID: 20345916
[TBL] [Abstract][Full Text] [Related]
29. Application of a protein synthesis inhibitor into the ventral tegmental area, but not the nucleus accumbens, prevents behavioral sensitization to cocaine.
Sorg BA; Ulibarri C
Synapse; 1995 Jul; 20(3):217-24. PubMed ID: 7570353
[TBL] [Abstract][Full Text] [Related]
30. Injection of SCH 23390 into the ventral tegmental area blocks the development of neurochemical but not behavioral sensitization to cocaine.
Steketee JD
Behav Pharmacol; 1998 Feb; 9(1):69-76. PubMed ID: 9832950
[TBL] [Abstract][Full Text] [Related]
31. The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations.
Feldpausch DL; Needham LM; Stone MP; Althaus JS; Yamamoto BK; Svensson KA; Merchant KM
J Pharmacol Exp Ther; 1998 Jul; 286(1):497-508. PubMed ID: 9655895
[TBL] [Abstract][Full Text] [Related]
32. Neutralization of neutrophin-3 in the ventral tegmental area or nucleus accumbens differentially modulates cocaine-induced behavioral plasticity in rats.
Freeman AY; Pierce RC
Synapse; 2002 Nov; 46(2):57-65. PubMed ID: 12211082
[TBL] [Abstract][Full Text] [Related]
33. Neurotensin receptor antagonist SR 142948A alters Fos expression and extrapyramidal side effect profile of typical and atypical antipsychotic drugs.
Binder EB; Kinkead B; Owens MJ; Nemeroff CB
Neuropsychopharmacology; 2004 Dec; 29(12):2200-7. PubMed ID: 15328528
[TBL] [Abstract][Full Text] [Related]
34. Repeated injection of GBR 12909, but not cocaine or WIN 35,065-2, into the ventral tegmental area induces behavioral sensitization.
Steketee JD
Behav Brain Res; 1998 Dec; 97(1-2):39-48. PubMed ID: 9867229
[TBL] [Abstract][Full Text] [Related]
35. Requirement of endogenous basic fibroblast growth factor for sensitization to amphetamine.
Flores C; Samaha AN; Stewart J
J Neurosci; 2000 Jan; 20(2):RC55. PubMed ID: 10632621
[TBL] [Abstract][Full Text] [Related]
36. Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on the locomotor and sensitizating effects of cocaine in rats.
Przegaliński E; Papla I; Siwanowicz J; Filip M
Eur Neuropsychopharmacol; 2004 May; 14(3):217-25. PubMed ID: 15056481
[TBL] [Abstract][Full Text] [Related]
37. Antagonism of Neurotensin Receptors in the Ventral Tegmental Area Decreases Methamphetamine Self-Administration and Methamphetamine Seeking in Mice.
Dominguez-Lopez S; Piccart E; Lynch WB; Wollet MB; Sharpe AL; Beckstead MJ
Int J Neuropsychopharmacol; 2018 Apr; 21(4):361-370. PubMed ID: 29272412
[TBL] [Abstract][Full Text] [Related]
38. Ibotenic acid lesions of prefrontal cortex do not prevent expression of behavioral sensitization to amphetamine.
Li Y; Wolf ME
Behav Brain Res; 1997 Mar; 84(1-2):285-9. PubMed ID: 9079793
[TBL] [Abstract][Full Text] [Related]
39. Short-term development of behavioral sensitization to amphetamine requires N-methyl-D-aspartate- and nicotinic-dependent mechanisms in the nucleus accumbens.
Degoulet M; Rostain JC; Abraini JH; David HN
Addict Biol; 2013 May; 18(3):417-24. PubMed ID: 21309959
[TBL] [Abstract][Full Text] [Related]
40. 5-HT
Faton S; Tassin JP; Duranton F; Bagnol D; Lajoix AD
Behav Brain Res; 2018 Jul; 347():234-241. PubMed ID: 29555337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
